Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses

Cell Metabolism

Volumn 26, Issue 1, 2017, Pages 142-156

  Stienstra, Rinke ^a,b   Netea Maier, Romana T ^a   Riksen, Niels P ^a   Joosten, Leo A B ^a   Netea, Mihai G ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

immunometabolism; innate immune response; metabolic complexity; myeloid cells; Warburg effect

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE;

AMINO ACID METABOLISM; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BONE MARROW CELL; CELL ACTIVATION; CELL METABOLISM; CELLULAR IMMUNITY; DISEASE SEVERITY; GLUCOSE METABOLISM; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; LIPID METABOLISM; MALIGNANT NEOPLASM; MICROENVIRONMENT; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEPSIS; ANIMAL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; METABOLIC NETWORKS AND PATHWAYS; MYELOID CELLS; NEOPLASMS; SEPSIS;

EID: 85028775096     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.06.001     Document Type: Review

References (142)

1. Aarup, A., Pedersen, T.X., Junker, N., Christoffersen, C., Bartels, E.D., Madsen, M., Nielsen, C.H., Nielsen, L.B., Hypoxia-inducible factor-1alpha expression in macrophages promotes development of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 36 (2016), 1782–1790.
2. Akira, S., Misawa, T., Satoh, T., Saitoh, T., Macrophages control innate inflammation. Diabetes Obes. Metab. 15:Suppl 3 (2013), 10–18.
3. Arts, R.J., Carvalho, A., La Rocca, C., Palma, C., Rodrigues, F., Silvestre, R., Kleinnijenhuis, J., Lachmandas, E., Goncalves, L.G., Belinha, A., et al. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep. 17 (2016), 2562–2571.
4. Arts, R.J., Joosten, L.A., Netea, M.G., Immunometabolic circuits in trained immunity. Semin. Immunol. 28 (2016), 425–430.
5. Arts, R.J., Novakovic, B., Ter Horst, R., Carvalho, A., Bekkering, S., Lachmandas, E., Rodrigues, F., Silvestre, R., Cheng, S.C., Wang, S.Y., et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24 (2016), 807–819.
6. Arts, R.J., Plantinga, T.S., Tuit, S., Ulas, T., Heinhuis, B., Tesselaar, M., Sloot, Y., Adema, G.J., Joosten, L.A., Smit, J.W., et al. Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages. Oncoimmunology, 5, 2016, e1229725.
7. Artyomov, M.N., Sergushichev, A., Schilling, J.D., Integrating immunometabolism and macrophage diversity. Semin. Immunol. 28 (2016), 417–424.
8. Asgharzadeh, S., Salo, J.A., Ji, L., Oberthuer, A., Fischer, M., Berthold, F., Hadjidaniel, M., Liu, C.W., Metelitsa, L.S., Pique-Regi, R., et al. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J. Clin. Oncol. 30 (2012), 3525–3532.
9. Azevedo, E.P., Rochael, N.C., Guimaraes-Costa, A.B., de Souza-Vieira, T.S., Ganilho, J., Saraiva, E.M., Palhano, F.L., Foguel, D., A metabolic shift toward pentose phosphate pathway is necessary for amyloid fibril- and phorbol 12-myristate 13-acetate-induced neutrophil extracellular trap (NET) formation. J. Biol. Chem. 290 (2015), 22174–22183.
10. Bekkering, S., van den Munckhof, I., Nielen, T., Lamfers, E., Dinarello, C., Rutten, J., de Graaf, J., Joosten, L.A., Netea, M.G., Gomes, M.E., et al. Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis 254 (2016), 228–236.
11. Biniecka, M., Canavan, M., McGarry, T., Gao, W., McCormick, J., Cregan, S., Gallagher, L., Smith, T., Phelan, J.J., Ryan, J., et al. Dysregulated bioenergetics: a key regulator of joint inflammation. Ann. Rheum. Dis. 75 (2016), 2192–2200.
12. Biswas, S.K., Mantovani, A., Orchestration of metabolism by macrophages. Cell Metab. 15 (2012), 432–437.
13. Biswas, S.K., Allavena, P., Mantovani, A., Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin. Immunopathol. 35 (2013), 585–600.
14. Borregaard, N., Herlin, T., Energy metabolism of human neutrophils during phagocytosis. J. Clin. Invest. 70 (1982), 550–557.
15. Bostrom, P., Magnusson, B., Svensson, P.A., Wiklund, O., Boren, J., Carlsson, L.M., Stahlman, M., Olofsson, S.O., Hulten, L.M., Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler. Thromb. Vasc. Biol. 26 (2006), 1871–1876.
16. Bowdish, D.M., Loffredo, M.S., Mukhopadhyay, S., Mantovani, A., Gordon, S., Macrophage receptors implicated in the “adaptive” form of innate immunity. Microbes Infect. 9 (2007), 1680–1687.
17. Buck, M.D., O'Sullivan, D., Pearce, E.L., T cell metabolism drives immunity. J. Exp. Med. 212 (2015), 1345–1360.
18. Caillou, B., Talbot, M., Weyemi, U., Pioche-Durieu, C., Al Ghuzlan, A., Bidart, J.M., Chouaib, S., Schlumberger, M., Dupuy, C., Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma. PLoS One, 6, 2011, e22567.
19. Carmona-Fontaine, C., Bucci, V., Akkari, L., Deforet, M., Joyce, J.A., Xavier, J.B., Emergence of spatial structure in the tumor microenvironment due to the Warburg effect. Proc. Natl. Acad. Sci. USA 110 (2013), 19402–19407.
20. Cheng, S.C., Quintin, J., Cramer, R.A., Shepardson, K.M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E.J., Martens, J.H., Rao, N.A., Aghajanirefah, A., et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science, 345, 2014, 1250684.
21. Cheng, S.C., Scicluna, B.P., Arts, R.J., Gresnigt, M.S., Lachmandas, E., Giamarellos-Bourboulis, E.J., Kox, M., Manjeri, G.R., Wagenaars, J.A., Cremer, O.L., et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17 (2016), 406–413.
22. Choi, J., Stradmann-Bellinghausen, B., Yakubov, E., Savaskan, N.E., Regnier-Vigouroux, A., Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages. Cancer Biol. Ther. 16 (2015), 1205–1213.
23. Cleophas, M.C., Crisan, T.O., Joosten, L.A., Factors modulating the inflammatory response in acute gouty arthritis. Curr. Opin. Rheumatol. 29 (2017), 163–170.
24. Cohn, Z.A., Morse, S.I., Functional and metabolic properties of polymorphonuclear leucocytes. I. Observations on the requirements and consequences of particle ingestion. J. Exp. Med. 111 (1960), 667–687.
25. Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., Jairam, V., Cyrus, N., Brokowski, C.E., Eisenbarth, S.C., Phillips, G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
26. Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A., Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30 (2009), 1073–1081.
27. Corzo, C.A., Condamine, T., Lu, L., Cotter, M.J., Youn, J.I., Cheng, P., Cho, H.I., Celis, E., Quiceno, D.G., Padhya, T., et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207 (2010), 2439–2453.
28. Cutolo, M., Sulli, A., Pizzorni, C., Seriolo, B., Straub, R.H., Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann. Rheum. Dis. 60 (2001), 729–735.
29. Daurkin, I., Eruslanov, E., Stoffs, T., Perrin, G.Q., Algood, C., Gilbert, S.M., Rosser, C.J., Su, L.M., Vieweg, J., Kusmartsev, S., Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res. 71 (2011), 6400–6409.
30. Dinarello, C.A., Simon, A., van der Meer, J.W., Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11 (2012), 633–652.
31. Donnelly, R.P., Loftus, R.M., Keating, S.E., Liou, K.T., Biron, C.A., Gardiner, C.M., Finlay, D.K., mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function. J. Immunol. 193 (2014), 4477–4484.
32. Dwarakanath, B.S., Singh, D., Banerji, A.K., Sarin, R., Venkataramana, N.K., Jalali, R., Vishwanath, P.N., Mohanti, B.K., Tripathi, R.P., Kalia, V.K., et al. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. J. Cancer Res. Ther. 5:Suppl 1 (2009), S21–S26.
33. Emami, H., Singh, P., MacNabb, M., Vucic, E., Lavender, Z., Rudd, J.H., Fayad, Z.A., Lehrer-Graiwer, J., Korsgren, M., Figueroa, A.L., et al. Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. JACC Cardiovasc. Imaging 8 (2015), 121–130.
34. Emanuel, R., Sergin, I., Bhattacharya, S., Turner, J.N., Epelman, S., Settembre, C., Diwan, A., Ballabio, A., Razani, B., Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1942–1952.
35. Everts, B., Amiel, E., Huang, S.C., Smith, A.M., Chang, C.H., Lam, W.Y., Redmann, V., Freitas, T.C., Blagih, J., van der Windt, G.J., et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat. Immunol. 15 (2014), 323–332.
36. Fearon, U., Canavan, M., Biniecka, M., Veale, D.J., Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat. Rev. Rheumatol. 12 (2016), 385–397.
37. Feig, J.E., Rong, J.X., Shamir, R., Sanson, M., Vengrenyuk, Y., Liu, J., Rayner, K., Moore, K., Garabedian, M., Fisher, E.A., HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl. Acad. Sci. USA 108 (2011), 7166–7171.
38. 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J. Am. Coll. Cardiol. 58 (2011), 603–614.
39. Fox, C.J., Hammerman, P.S., Thompson, C.B., Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5 (2005), 844–852.
40. Freemerman, A.J., Johnson, A.R., Sacks, G.N., Milner, J.J., Kirk, E.L., Troester, M.A., Macintyre, A.N., Goraksha-Hicks, P., Rathmell, J.C., Makowski, L., Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J. Biol. Chem. 289 (2014), 7884–7896.
41. 2! See what HIF can do!. Ann. Rheum. Dis. 64 (2005), 971–980.
42. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9 (2009), 162–174.
43. Garcia-Carbonell, R., Divakaruni, A.S., Lodi, A., Vicente-Suarez, I., Saha, A., Cheroutre, H., Boss, G.R., Tiziani, S., Murphy, A.N., Guma, M., Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 68 (2016), 1614–1626.
44. Gautier, E.L., Westerterp, M., Bhagwat, N., Cremers, S., Shih, A., Abdel-Wahab, O., Lutjohann, D., Randolph, G.J., Levine, R.L., Tall, A.R., et al. HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders. J. Exp. Med. 210 (2013), 339–353.
45. Gleeson, L.E., Sheedy, F.J., Metabolic reprogramming and inflammation: fuelling the host response to pathogens. Semin. Immunol. 28 (2016), 450–468.
46. Haas, R., Smith, J., Rocher-Ros, V., Nadkarni, S., Montero-Melendez, T., D'Acquisto, F., Bland, E.J., Bombardieri, M., Pitzalis, C., Perretti, M., et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol., 13, 2015, e1002202.
47. Haimovich, B., Reddell, M.T., Calvano, J.E., Calvano, S.E., Macor, M.A., Coyle, S.M., Lowry, S.F., A novel model of common Toll-like receptor 4- and injury-induced transcriptional themes in human leukocytes. Crit. Care, 14, 2010, R177.
48. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
49. Haschemi, A., Kosma, P., Gille, L., Evans, C.R., Burant, C.F., Starkl, P., Knapp, B., Haas, R., Schmid, J.A., Jandl, C., et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 15 (2012), 813–826.
50. Huang, S.C., Everts, B., Ivanova, Y., O'Sullivan, D., Nascimento, M., Smith, A.M., Beatty, W., Love-Gregory, L., Lam, W.Y., O'Neill, C.M., et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat. Immunol. 15 (2014), 846–855.
51. Huang, S.C., Smith, A.M., Everts, B., Colonna, M., Pearce, E.L., Schilling, J.D., Pearce, E.J., Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity 45 (2016), 817–830.
52. Im, S.S., Yousef, L., Blaschitz, C., Liu, J.Z., Edwards, R.A., Young, S.G., Raffatellu, M., Osborne, T.F., Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab. 13 (2011), 540–549.
53. Ip, W.K.E., Hoshi, N., Shouval, D.S., Snapper, S., Medzhitov, R., Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356 (2017), 513–519.
54. Jha, A.K., Huang, S.C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K.M., Ashall, J., Everts, B., et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42 (2015), 419–430.
55. Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9 (2009), 239–252.
56. Kanter, J.E., Kramer, F., Barnhart, S., Averill, M.M., Vivekanandan-Giri, A., Vickery, T., Li, L.O., Becker, L., Yuan, W., Chait, A., et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA 109 (2012), E715–E724.
57. Kareva, I., Hahnfeldt, P., The emerging “hallmarks” of metabolic reprogramming and immune evasion: distinct or linked?. Cancer Res. 73 (2013), 2737–2742.
58. Kelly, B., O'Neill, L.A., Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25 (2015), 771–784.
59. Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L.A., Ifrim, D.C., Saeed, S., Jacobs, C., van Loenhout, J., de Jong, D., Stunnenberg, H.G., et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl. Acad. Sci. USA 109 (2012), 17537–17542.
60. Krawczyk, C.M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R.J., Cross, J.R., Jung, E., Thompson, C.B., Jones, R.G., et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115 (2010), 4742–4749.
61. Kurtz, J., Specific memory within innate immune systems. Trends Immunol. 26 (2005), 186–192.
62. Lachmandas, E., Boutens, L., Ratter, J.M., Hijmans, A., Hooiveld, G.J., Joosten, L.A., Rodenburg, R.J., Fransen, J.A., Houtkooper, R.H., van Crevel, R., et al. Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat. Microbiol., 2, 2016, 16246.
63. Lampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E.E., Loginicheva, E., Cervantes-Barragan, L., Ma, X., Huang, S.C., Griss, T., et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24 (2016), 158–166.
64. Lee, J., Zhang, T., Hwang, I., Kim, A., Nitschke, L., Kim, M., Scott, J.M., Kamimura, Y., Lanier, L.L., Kim, S., Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 42 (2015), 431–442.
65. Leentjens, J., Kox, M., Koch, R.M., Preijers, F., Joosten, L.A., van der Hoeven, J.G., Netea, M.G., Pickkers, P., Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am. J. Respir. Crit. Care Med. 186 (2012), 838–845.
66. Littlewood-Evans, A., Sarret, S., Apfel, V., Loesle, P., Dawson, J., Zhang, J., Muller, A., Tigani, B., Kneuer, R., Patel, S., et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J. Exp. Med. 213 (2016), 1655–1662.
67. +-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. J. Biol. Chem. 287 (2012), 25758–25769.
68. Liu, D., Chang, C., Lu, N., Wang, X., Lu, Q., Ren, X., Ren, P., Zhao, D., Wang, L., Zhu, Y., et al. Comprehensive proteomics analysis reveals metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment. J. Proteome Res. 16 (2017), 288–297.
69. MacDonald, M.L., van Eck, M., Hildebrand, R.B., Wong, B.W., Bissada, N., Ruddle, P., Kontush, A., Hussein, H., Pouladi, M.A., Chapman, M.J., et al. Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 341–347.
70. Macintyre, A.N., Gerriets, V.A., Nichols, A.G., Michalek, R.D., Rudolph, M.C., Deoliveira, D., Anderson, S.M., Abel, E.D., Chen, B.J., Hale, L.P., et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20 (2014), 61–72.
71. Mantovani, A., Biswas, S.K., Galdiero, M.R., Sica, A., Locati, M., Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229 (2013), 176–185.
72. Markov, A.K., Neely, W.A., Didlake, R.H., Terry, J. 3rd, Causey, A., Lehan, P.H., Metabolic responses to fructose-1,6-diphosphate in healthy subjects. Metabolism 49 (2000), 698–703.
73. Mauer, J., Chaurasia, B., Goldau, J., Vogt, M.C., Ruud, J., Nguyen, K.D., Theurich, S., Hausen, A.C., Schmitz, J., Bronneke, H.S., et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 15 (2014), 423–430.
74. Mills, C.D., M1 and M2 macrophages: oracles of health and disease. Crit. Rev. Immunol. 32 (2012), 463–488.
75. Mills, E.L., Kelly, B., Logan, A., Costa, A.S., Varma, M., Bryant, C.E., Tourlomousis, P., Dabritz, J.H., Gottlieb, E., Latorre, I., et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167 (2016), 457–470.e13.
76. Moore, G.Y., Pidgeon, G.P., Cross-talk between cancer cells and the tumour microenvironment: the role of the 5-lipoxygenase pathway. Int. J. Mol. Sci., 18, 2017, 10.3390/ijms18020236.
77. Morten, K.J., Badder, L., Knowles, H.J., Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J. Pathol. 229 (2013), 755–764.
78. Murray, P.J., Wynn, T.A., Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11 (2011), 723–737.
79. Nagy, C., Haschemi, A., Time and demand are two critical dimensions of immunometabolism: the process of macrophage activation and the pentose phosphate pathway. Front. Immunol., 6, 2015, 164.
80. Netea, M.G., van der Meer, J.W., Trained immunity: an ancient way of remembering. Cell Host Microbe 21 (2017), 297–300.
81. Netea, M.G., Quintin, J., van der Meer, J.W., Trained immunity: a memory for innate host defense. Cell Host Microbe 9 (2011), 355–361.
82. Netea, M.G., Joosten, L.A., Latz, E., Mills, K.H., Natoli, G., Stunnenberg, H.G., O'Neill, L.A., Xavier, R.J., Trained immunity: a program of innate immune memory in health and disease. Science, 352, 2016, aaf1098.
83. Nishizawa, T., Kanter, J.E., Kramer, F., Barnhart, S., Shen, X., Vivekanandan-Giri, A., Wall, V.Z., Kowitz, J., Devaraj, S., O'Brien, K.D., et al. Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis. Cell Rep. 7 (2014), 356–365.
84. Nonomura, N., Takayama, H., Nakayama, M., Nakai, Y., Kawashima, A., Mukai, M., Nagahara, A., Aozasa, K., Tsujimura, A., Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU Int. 107 (2011), 1918–1922.
85. Noy, R., Pollard, J.W., Tumor-associated macrophages: from mechanisms to therapy. Immunity 41 (2014), 49–61.
86. O'Neill, L.A., A critical role for citrate metabolism in LPS signalling. Biochem. J. 438 (2011), e5–e6.
87. O'Neill, L.A., Pearce, E.J., Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213 (2016), 15–23.
88. O'Neill, L.A., Kishton, R.J., Rathmell, J., A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16 (2016), 553–565.
89. Odegaard, J.I., Chawla, A., Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6 (2011), 275–297.
90. Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A.W., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447 (2007), 1116–1120.
91. Oren, R., Farnham, A.E., Saito, K., Milofsky, E., Karnovsky, M.L., Metabolic patterns in three types of phagocytizing cells. J. Cell Biol. 17 (1963), 487–501.
92. Ouimet, M., Ediriweera, H.N., Gundra, U.M., Sheedy, F.J., Ramkhelawon, B., Hutchison, S.B., Rinehold, K., van Solingen, C., Fullerton, M.D., Cecchini, K., et al. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J. Clin. Invest. 125 (2015), 4334–4348.
93. Palsson-McDermott, E.M., Curtis, A.M., Goel, G., Lauterbach, M.A., Sheedy, F.J., Gleeson, L.E., van den Bosch, M.W., Quinn, S.R., Domingo-Fernandez, R., Johnston, D.G., et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 21 (2015), 65–80.
94. Papavasiliou, F.N., Chung, Y.C., Gagnidze, K., Hajdarovic, K.H., Cole, D.C., Bulloch, K., Epigenetic modulators of monocytic function: implication for steady state and disease in the CNS. Front. Immunol., 6, 2015, 661.
95. Pearce, E.J., Everts, B., Dendritic cell metabolism. Nat. Rev. Immunol. 15 (2015), 18–29.
96. Pearce, E.L., Pearce, E.J., Metabolic pathways in immune cell activation and quiescence. Immunity 38 (2013), 633–643.
97. Pearce, E.L., Poffenberger, M.C., Chang, C.H., Jones, R.G., Fueling immunity: insights into metabolism and lymphocyte function. Science, 342, 2013, 1242454.
98. Penny, H.L., Sieow, J.L., Adriani, G., Yeap, W.H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S.Y., Ho, Y.S., et al. Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. Oncoimmunology, 5, 2016, e1191731.
99. Poczobutt, J.M., De, S., Yadav, V.K., Nguyen, T.T., Li, H., Sippel, T.R., Weiser-Evans, M.C., Nemenoff, R.A., Expression profiling of macrophages reveals multiple populations with distinct biological roles in an immunocompetent orthotopic model of lung cancer. J. Immunol. 196 (2016), 2847–2859.
100. Psaila, B., Lyden, D., The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 9 (2009), 285–293.
101. Qian, B.Z., Pollard, J.W., Macrophage diversity enhances tumor progression and metastasis. Cell 141 (2010), 39–51.
102. Quintin, J., Saeed, S., Martens, J.H., Giamarellos-Bourboulis, E.J., Ifrim, D.C., Logie, C., Jacobs, L., Jansen, T., Kullberg, B.J., Wijmenga, C., et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12 (2012), 223–232.
103. Quintin, J., Cheng, S.C., van der Meer, J.W., Netea, M.G., Innate immune memory: towards a better understanding of host defense mechanisms. Curr. Opin. Immunol. 29 (2014), 1–7.
104. Rao, E., Singh, P., Zhai, X., Li, Y., Zhu, G., Zhang, Y., Hao, J., Chi, Y.I., Brown, R.E., Cleary, M.P., et al. Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein. Oncotarget 6 (2015), 7815–7827.
105. Reiss, M., Roos, D., Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J. Clin. Invest. 61 (1978), 480–488.
106. Rodriguez-Prados, J.C., Traves, P.G., Cuenca, J., Rico, D., Aragones, J., Martin-Sanz, P., Cascante, M., Bosca, L., Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J. Immunol. 185 (2010), 605–614.
107. Ruiz-Garcia, A., Monsalve, E., Novellasdemunt, L., Navarro-Sabate, A., Manzano, A., Rivero, S., Castrillo, A., Casado, M., Laborda, J., Bartrons, R., et al. Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene. J. Biol. Chem. 286 (2011), 19247–19258.
108. Ryder, M., Ghossein, R.A., Ricarte-Filho, J.C., Knauf, J.A., Fagin, J.A., Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr. Relat. Cancer 15 (2008), 1069–1074.
109. Saeed, S., Quintin, J., Kerstens, H.H., Rao, N.A., Aghajanirefah, A., Matarese, F., Cheng, S.C., Ratter, J., Berentsen, K., van der Ent, M.A., et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science, 345, 2014, 1251086.
110. Sag, D., Carling, D., Stout, R.D., Suttles, J., Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181 (2008), 8633–8641.
111. Sarrazy, V., Viaud, M., Westerterp, M., Ivanov, S., Giorgetti-Peraldi, S., Guinamard, R., Gautier, E.L., Thorp, E.B., De Vivo, D.C., Yvan-Charvet, L., Disruption of Glut1 in hematopoietic stem cells prevents myelopoiesis and enhanced glucose flux in atheromatous plaques of ApoE(-/-) mice. Circ. Res. 118 (2016), 1062–1077.
112. Sbarra, A.J., Shirley, W., Phagocytosis inhibition and reversal. I. Effect of glycolytic intermediates and nucleotides on particle uptake. J. Bacteriol. 86 (1963), 259–265.
113. Schneider, J.G., Yang, Z., Chakravarthy, M.V., Lodhi, I.J., Wei, X., Turk, J., Semenkovich, C.F., Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. J. Biol. Chem. 285 (2010), 23398–23409.
114. Semba, H., Takeda, N., Isagawa, T., Sugiura, Y., Honda, K., Wake, M., Miyazawa, H., Yamaguchi, Y., Miura, M., Jenkins, D.M., et al. HIF-1alpha-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity. Nat. Commun., 7, 2016, 11635.
115. Sergin, I., Evans, T.D., Razani, B., Degradation and beyond: the macrophage lysosome as a nexus for nutrient sensing and processing in atherosclerosis. Curr. Opin. Lipidol. 26 (2015), 394–404.
116. Sheedy, F.J., Grebe, A., Rayner, K.J., Kalantari, P., Ramkhelawon, B., Carpenter, S.B., Becker, C.E., Ediriweera, H.N., Mullick, A.E., Golenbock, D.T., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 14 (2013), 812–820.
117. Shirai, T., Nazarewicz, R.R., Wallis, B.B., Yanes, R.E., Watanabe, R., Hilhorst, M., Tian, L., Harrison, D.G., Giacomini, J.C., Assimes, T.L., et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J. Exp. Med. 213 (2016), 337–354.
118. Spann, N.J., Glass, C.K., Sterols and oxysterols in immune cell function. Nat. Immunol. 14 (2013), 893–900.
119. Spann, N.J., Garmire, L.X., McDonald, J.G., Myers, D.S., Milne, S.B., Shibata, N., Reichart, D., Fox, J.N., Shaked, I., Heudobler, D., et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151 (2012), 138–152.
120. Su, L., Li, H., Xie, A., Liu, D., Rao, W., Lan, L., Li, X., Li, F., Xiao, K., Wang, H., et al. Dynamic changes in amino acid concentration profiles in patients with sepsis. PLoS One, 10, 2015, e0121933.
121. Swirski, F.K., Libby, P., Aikawa, E., Alcaide, P., Luscinskas, F.W., Weissleder, R., Pittet, M.J., Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117 (2007), 195–205.
122. Tabas, I., Bornfeldt, K.E., Macrophage phenotype and function in different stages of atherosclerosis. Circ. Res. 118 (2016), 653–667.
123. Tall, A.R., Yvan-Charvet, L., Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15 (2015), 104–116.
124. Tan, Z., Xie, N., Banerjee, S., Cui, H., Fu, M., Thannickal, V.J., Liu, G., The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. J. Biol. Chem. 290 (2015), 46–55.
125. Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M., McGettrick, A.F., Goel, G., Frezza, C., Bernard, N.J., Kelly, B., Foley, N.H., et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496 (2013), 238–242.
126. Tawakol, A., Singh, P., Mojena, M., Pimentel-Santillana, M., Emami, H., MacNabb, M., Rudd, J.H., Narula, J., Enriquez, J.A., Traves, P.G., et al. HIF-1alpha and PFKFB3 mediate a tight relationship between proinflammatory activation and anerobic metabolism in atherosclerotic macrophages. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1463–1471.
127. Traves, P.G., de Atauri, P., Marin, S., Pimentel-Santillana, M., Rodriguez-Prados, J.C., Marin de Mas, I., Selivanov, V.A., Martin-Sanz, P., Bosca, L., Cascante, M., Relevance of the MEK/ERK signaling pathway in the metabolism of activated macrophages: a metabolomic approach. J. Immunol. 188 (2012), 1402–1410.
128. Udalova, I.A., Mantovani, A., Feldmann, M., Macrophage heterogeneity in the context of rheumatoid arthritis. Nat. Rev. Rheumatol. 12 (2016), 472–485.
129. + T cell memory development. Immunity 36 (2012), 68–78.
130. van Diepen, J.A., Thiem, K., Stienstra, R., Riksen, N.P., Tack, C.J., Netea, M.G., Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?. Cell Mol. Life Sci. 73 (2016), 4675–4684.
131. Wang, D., Dubois, R.N., Eicosanoids and cancer. Nat. Rev. Cancer 10 (2010), 181–193.
132. Warburg, O., On the origin of cancer cells. Science 123 (1956), 309–314.
133. Wenes, M., Shang, M., Di Matteo, M., Goveia, J., Martin-Perez, R., Serneels, J., Prenen, H., Ghesquiere, B., Carmeliet, P., Mazzone, M., Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis. Cell Metab. 24 (2016), 701–715.
134. Wu, T., Sun, C., Chen, Z., Zhen, Y., Peng, J., Qi, Z., Yang, X., Zhao, Y., Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J. Immunol. 189 (2012), 4989–5000.
135. Xu, X., Grijalva, A., Skowronski, A., van Eijk, M., Serlie, M.J., Ferrante, A.W. Jr., Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18 (2013), 816–830.
136. Xue, J., Schmidt, S.V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T.D., Emde, M., Schmidleithner, L., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40 (2014), 274–288.
137. Yamashita, A., Zhao, Y., Matsuura, Y., Yamasaki, K., Moriguchi-Goto, S., Sugita, C., Iwakiri, T., Okuyama, N., Koshimoto, C., Kawai, K., et al. Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage. PLoS One, 9, 2014, e86426.
138. Yang, Z., Fujii, H., Mohan, S.V., Goronzy, J.J., Weyand, C.M., Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J. Exp. Med. 210 (2013), 2119–2134.
139. Yang, Z., Goronzy, J.J., Weyand, C.M., The glycolytic enzyme PFKFB3/phosphofructokinase regulates autophagy. Autophagy 10 (2014), 382–383.
140. Zhang, Y., Sun, Y., Rao, E., Yan, F., Li, Q., Zhang, Y., Silverstein, K.A., Liu, S., Sauter, E., Cleary, M.P., et al. Fatty acid-binding protein E-FABP restricts tumor growth by promoting IFN-beta responses in tumor-associated macrophages. Cancer Res. 74 (2014), 2986–2998.
141. Zhu, L., Zhao, Q., Yang, T., Ding, W., Zhao, Y., Cellular metabolism and macrophage functional polarization. Int. Rev. Immunol. 34 (2015), 82–100.
142. Zhu, Y.P., Brown, J.R., Sag, D., Zhang, L., Suttles, J., Adenosine 5’-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages. J. Immunol. 194 (2015), 584–594.